![Don Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Don Bailey
Directeur/Membre du Conseil chez
Chapman University
Profil
Don Matthew Bailey currently works at Chapman University, as Director, the University of California, Irvine, as Director-Applied Innovation Institute, and Cove Management LLC, as Advisor.
Mr. Bailey also formerly worked at Questcor Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2007 to 2014, Comarco, Inc., as Chairman from 2000 to 2007, Asterias Biotherapeutics, Inc., as Non-Executive Chairman from 2016 to 2019, STAAR Surgical Co., as Independent Director in 2014, Mallinckrodt Plc, as Independent Director from 2015 to 2016, Biotie Therapies Oy, as Independent Director from 2015 to 2016, Canon STAAR Co., Inc., as Director, Lineage Cell Therapeutics, Inc., as Independent Director from 2020 to 2025, and Insight Molecular Diagnostics, Inc., as Independent Director from 2016 to 2017.
Mr. Bailey received his graduate degree in 1971 from the University of Southern California, undergraduate degree in 1968 from Drexel University, and Masters Business Admin degree in 1986 from Pepperdine University.
Postes actifs de Don Bailey
| Sociétés | Poste | Début |
|---|---|---|
Chapman University
 Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cove Management LLC
 Cove Management LLC Investment ManagersFinance Cove Fund invests in companies located in the United States, primarily in Southern California. The firm targets companies operating in the fields of technology and life sciences sectors. It provides financing for seed stage capital requirements with an investment size of USD 0.25 - 1 million. and a transaction size of USD 1 - 5 million. It acts as a lead investor and takes a seat on the board of directors. | Consultant / Advisor | - |
Anciens postes connus de Don Bailey
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 26/06/2025 |
| ASTERIAS BIOTHERAPEUTICS INC | Président | 08/03/2019 |
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Directeur/Membre du Conseil | 18/11/2017 |
| BIOTIE THERAPIES CORP | Directeur/Membre du Conseil | 01/05/2016 |
| MALLINCKRODT PLC | Directeur/Membre du Conseil | 01/03/2016 |
Formation de Don Bailey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Comarco, Inc.
 Comarco, Inc. Wireless TelecommunicationsCommunications Provides programmable slim and light universal power products | Communications |
STAAR Surgical Co.
 STAAR Surgical Co. Medical SpecialtiesHealth Technology Designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye | Health Technology |
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chapman University
Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canon STAAR Co., Inc.
 Canon STAAR Co., Inc. Medical SpecialtiesHealth Technology Produces, imports and sells intra-ocular lenses for cataract treatment | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Cove Management LLC
Cove Management LLC Investment ManagersFinance Cove Fund invests in companies located in the United States, primarily in Southern California. The firm targets companies operating in the fields of technology and life sciences sectors. It provides financing for seed stage capital requirements with an investment size of USD 0.25 - 1 million. and a transaction size of USD 1 - 5 million. It acts as a lead investor and takes a seat on the board of directors. | Finance |
